Delisting risk
BioVie (BIVI)
Develops bezisterim and continuous-infusion terlipressin therapies.
$2.02
Pre-market−0.00 (−0.02%)
At close$2.02(−9.82%)
Something off on this page? Send us feedback.
Breakdown13F · 13D/G · Form 4
| Institutions32 holders · as of Mar 31, 2026 | 13.67% | 1.03M shares | |
| Insiders6 holders · as of Aug 28, 2026 | 0.58% | 44.1K shares | |
| Strategic holders1 holder · as of Aug 19, 2026 | 9.11% | 687.3K shares | |
| Otherremainder | 76.64% | 5.78M shares |
7.54M company shares as of Sep 3, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing
Institutions13F, as of Mar 31, 2026
32 holders · 1.03M shares · 7 new positions · 14 increased · 4 reduced · 10 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Diametric Capital, LP | 370.0K | 4.91% | 0 | May 15, 2026 |
| Prelude Capital Management, LLC | 92.1K | 1.22% | 0 | May 15, 2026 |
| Geode Capital Management, LLC | 84.2K | 1.12% | +28.8K | May 15, 2026 |
| Vanguard Capital Management LLC | 84.1K | 1.11% | +84.1Knew | May 15, 2026 |
| Morgan Stanley | 75.2K | 1.00% | +15.0K | May 15, 2026 |
| Philadelphia Trust Co | 75.0K | 0.99% | 0 | May 13, 2026 |
| Renaissance Technologies LLC | 67.9K | 0.90% | +39.9K | May 14, 2026 |
| Citadel Advisors LLC | 45.3K | 0.60% | +27.1K | May 15, 2026 |
Ownership statements13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Terren S. Peizerincl. Acuitas Group Holdings, LLC | 15.80% | 13D | Jun 30, 2025 ↗ | |
| Alta Partners LLC | 8.40% | 687.3K | 13G | Aug 19, 2026 ↗ |
| Morgan Stanley | 8.00% | 605.5K | 13G | Aug 7, 2026 ↗ |
| Management LLCincl. Maier Joshua Tarlow, 3i, LP +1 more | 7.60% | 13G | Oct 25, 2024 ↗ | |
| Do Cuong Vincl. Do & Rickles Investments, LLC | 5.03% | 399.0K | 13D | Mar 25, 2026 ↗ |
Insider tradesForm 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Aug 27, 2026 | Cuong V. Dodirector, officer: President & CEO | Purchase | 15,210 | $2.08 | 16,117 |
| Aug 28, 2026 | Joanne Wendy Kimofficer: Chief Financial Officer | Purchase | 2,500 | $2.18 | 3,441 |
| Aug 28, 2026 | Amy Suzon Chappelldirector | Purchase | 727 | $2.16 | 727 |
| Aug 28, 2026 | Joseph M. Palumboofficer: Chief Medical Officer | Purchase | 4,843 | $2.16 | 6,036 |
CongressHouse and Senate disclosures
Not reported.